Journal of Alzheimer s Disease Reports,
Journal Year:
2023,
Volume and Issue:
7(1), P. 957 - 972
Published: Aug. 22, 2023
Background:
While
Alzheimer’s
disease
(AD)
pathology
is
associated
with
altered
brain
structure,
it
not
clear
whether
gene
expression
changes
mirror
the
onset
and
evolution
of
in
distinct
regions.
Deciphering
mechanisms
which
cause
differential
manifestation
across
different
regions
has
potential
to
help
early
diagnosis.
Objective:
We
aimed
identify
common
unique
endotypes
their
regulation
tangle-free
neurons
sporadic
AD
(SAD)
six
regions:
entorhinal
cortex
(EC),
hippocampus
(HC),
medial
temporal
gyrus
(MTG),
posterior
cingulate
(PC),
superior
frontal
(SFG),
visual
(VCX).
Methods:
To
decipher
states
human
subjects
afflicted
AD,
we
performed
analysis
neural
transcriptome.
explored
expression,
functional
transcription
factor
target
enrichment,
co-expression
module
detection
discern
disease-state
transcriptomic
variances
characterize
endotypes.
Additionally,
compared
our
results
tangled
neuron
microarray-based
study
Allen
Brain
Atlas.
Results:
identified
impaired
function
EC,
MTG,
PC,
VCX
resulting
from
REST
activation
reversal
mature
a
precursor-like
state
SFG
linked
SOX2
activation.
decreased
increased
dedifferentiation
were
SUZ12.
Energetic
deficit
connected
NRF1
inactivation
was
found
HC,
VCX.
Conclusions:
Our
findings
suggest
that
SAD
varies
scale
severity
endotypes,
such
as
energetic
shortfalls,
neuronal
function,
dedifferentiation.
Frontiers in Molecular Neuroscience,
Journal Year:
2022,
Volume and Issue:
15
Published: Aug. 25, 2022
Regulated
cell
death
(RCD)
is
an
ordered
and
tightly
orchestrated
set
of
changes/signaling
events
in
both
gene
expression
protein
activity
responsible
for
normal
development
as
well
maintenance
tissue
homeostasis.
Aberrant
activation
this
pathway
results
by
various
mechanisms
including
apoptosis,
necroptosis,
pyroptosis,
ferroptosis,
autophagy-dependent
death.
Such
pathological
changes
neurons
alone
or
combination
have
been
observed
the
pathogenesis
neurodegenerative
diseases
Alzheimer’s
disease
(AD).
Pathological
hallmarks
AD
focus
primarily
on
accumulation
two
main
markers:
amyloid
β
peptides
abnormally
phosphorylated
tau
proteins.
These
aggregates
result
formation
A-β
plaques
neuro-fibrillary
tangles
(NFTs)
induce
neuroinflammation
neurodegeneration
over
years
to
decades
leading
a
multitude
cognitive
behavioral
deficits.
Autopsy
findings
reveal
massive
neuronal
manifested
form
cortical
volume
shrinkage,
reduction
sizes
gyri
up
50%
increase
sulci.
Multiple
forms
recorded
from
different
studies
conducted
so
far.
However,
understanding
mechanism/s
patients
remains
mystery
trigger
that
aberrant
RCD
unknown
because
limited
availability
dying
neurons.
This
review
attempts
elucidate
process
death,
how
it
gets
unregulated
response
intra
extracellular
stressors,
their
interplay
role
Disease
human
experimental
models
AD.
Further
we
plan
explore
correlation
amyloid-beta
Tau
with
loss
seen
Cell Metabolism,
Journal Year:
2022,
Volume and Issue:
34(9), P. 1248 - 1263.e6
Published: Aug. 19, 2022
The
drivers
of
sporadic
Alzheimer's
disease
(AD)
remain
incompletely
understood.
Utilizing
directly
converted
induced
neurons
(iNs)
from
AD-patient-derived
fibroblasts,
we
identified
a
metabolic
switch
to
aerobic
glycolysis
in
AD
iNs.
Pathological
isoform
switching
the
glycolytic
enzyme
pyruvate
kinase
M
(PKM)
toward
cancer-associated
PKM2
conferred
and
transcriptional
changes
These
alterations
occurred
via
PKM2's
lack
activity
nuclear
translocation
association
with
STAT3
HIF1α
promote
neuronal
fate
loss
vulnerability.
Chemical
modulation
prevented
translocation,
restored
mature
metabolism,
reversed
AD-specific
gene
expression
changes,
re-activated
resilience
against
cell
death.
Immunity,
Journal Year:
2023,
Volume and Issue:
57(1), P. 86 - 105.e9
Published: Dec. 29, 2023
Triggering
receptor
expressed
on
myeloid
cells
2
(Trem2)
is
a
cell-specific
gene
in
brain
microglia,
with
variants
that
are
associated
neurodegenerative
diseases,
including
Alzheimer's
disease.
Trem2
essential
for
microglia-mediated
synaptic
refinement,
but
whether
contributes
to
shaping
neuronal
development
remains
unclear.
Here,
we
demonstrate
plays
key
role
controlling
the
bioenergetic
profile
of
pyramidal
neurons
during
development.
In
absence
Trem2,
developing
hippocampal
cornus
ammonis
(CA)1
not
CA3
subfield
displayed
compromised
energetic
metabolism,
accompanied
by
reduced
mitochondrial
mass
and
abnormal
organelle
ultrastructure.
This
was
paralleled
transcriptional
rearrangement
at
birth,
pervasive
alteration
metabolic,
oxidative
phosphorylation,
signatures,
delay
maturation
CA1
neurons.
Our
results
unveil
regulating
metabolic
fitness
region-specific
manner.
Neurobiology of Disease,
Journal Year:
2024,
Volume and Issue:
197, P. 106520 - 106520
Published: May 3, 2024
Autism
spectrum
disorder
(ASD)
is
a
neurodevelopmental
affecting
1
in
36
children
and
associated
with
physiological
abnormalities,
most
notably
mitochondrial
dysfunction,
at
least
subset
of
individuals.
This
systematic
review
meta-analysis
discovered
204
relevant
articles
which
evaluated
biomarkers
dysfunction
ASD
Significant
elevations
(all
p
<
0.01)
the
prevalence
lactate
(17%),
pyruvate
(41%),
alanine
(15%)
creatine
kinase
(9%)
were
found
ASD.
Individuals
had
significant
differences
moderate
to
large
effect
sizes
(Cohen's
d'
≥
0.6)
compared
controls
mean
pyruvate,
lactate-to-pyruvate
ratio,
ATP,
kinase.
Some
studies
abnormal
TCA
cycle
metabolites
Thirteen
controlled
reported
DNA
(mtDNA)
deletions
or
variations
group
blood,
peripheral
blood
mononuclear
cells,
lymphocytes,
leucocytes,
granulocytes,
brain.
Meta-analyses
(p
copy
number
mtDNA
overall
ND1,
ND4
CytB
genes.
Four
linked
specific
haplogroups
A
series
subgroup
elevated
respiration
was
increased
sensitivity
mitochondria
stressors
regression.
Lactate,
carnitine,
acyl-carnitines
clinical
features
such
as
delays
language,
social
interaction,
cognition,
motor
skills,
repetitive
behaviors
gastrointestinal
symptoms,
although
not
all
an
association.
acyl-carnitines,
CoQ10,
well
variants,
heteroplasmy,
severity.
Variability
across
biomarker
primarily
due
collection
processing
techniques
intrinsic
heterogeneity
population.
Several
alterations
metabolism
mothers
neonates
who
develop
Treatments
targeting
mitochondria,
particularly
carnitine
ubiquinol,
appear
beneficial
The
link
between
common
abnormalities
individuals
including
disorders,
oxidative
stress,
immune
outlined.
subtypes
are
discussed,
one
related
regression,
another
microbiome
metabolites,
acyl-carnitines.
Mechanisms
linking
function
prenatal
brain
development
postnatal
Given
multisystem
complexity
some
ASD,
this
presents
evidence
for
being
central
by
contributing
development,
comorbidities
diagnostic
approach
identify
From
evidence,
it
clear
that
many
have
may
need
be
addressed
order
achieve
optimal
outcomes.
fact
during
pregnancy
early
life
eventually
provides
promise
predictive
Further
improve
understanding
role
better
defining
subgroups
molecular
mechanisms
driving
unique
changes
those
Journal of Translational Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: March 4, 2024
Abstract
Mitochondria
are
cytoplasmic
organelles
having
a
fundamental
role
in
the
regulation
of
neural
stem
cell
(NSC)
fate
during
development
and
maintenance.
During
embryonic
adult
neurogenesis,
NSCs
undergo
metabolic
switch
from
glycolytic
to
oxidative
phosphorylation
with
rise
mitochondrial
DNA
(mtDNA)
content,
changes
mitochondria
shape
size,
physiological
augmentation
reactive
oxygen
species
which
together
drive
proliferate
differentiate.
Genetic
epigenetic
modifications
proteins
involved
cellular
differentiation
(Mechanistic
Target
Rapamycin),
proliferation
(Wingless-type),
hypoxia
(Mitogen-activated
protein
kinase)–and
all
connected
by
common
key
regulatory
factor
Hypoxia
Inducible
Factor-1A–are
deemed
be
responsible
for
shift
and,
consequently,
NSC
pathological
conditions.
Both
primary
dysfunction
due
mutations
nuclear
or
mtDNA
secondary
(OXPHOS)
metabolism,
dynamics,
organelle
interplay
pathways
can
contribute
neurodevelopmental
progressive
neurodegenerative
disorders.
This
review
analyses
physiology
pathology
starting
available
vitro
vivo
models
highlights
current
knowledge
concerning
this
process.
Frontiers in Cellular Neuroscience,
Journal Year:
2024,
Volume and Issue:
18
Published: Jan. 30, 2024
Introduction
Down
syndrome,
caused
by
trisomy
21,
is
a
complex
developmental
disorder
associated
with
intellectual
disability
and
reduced
growth
of
multiple
organs.
Structural
pathologies
are
present
at
birth,
reflecting
embryonic
origins.
A
fundamental
unanswered
question
how
an
extra
copy
human
chromosome
21
contributes
to
organ-specific
that
characterize
individuals
and,
relevant
the
hallmark
in
affects
neural
development.
We
tested
hypothesis
exerts
effects
on
development
as
early
induction.
Methods
Bulk
RNA
sequencing
was
performed
isogenic
euploid
induced
pluripotent
stem
cells
(iPSCs)
successive
stages
induction:
embryoid
bodies
Day
6,
neuroectoderm
10,
differentiated
17.
Results
Gene
expression
analysis
revealed
over
1,300
differentially
expressed
genes
along
differentiation
pathway
compared
controls.
Less
than
5%
gene
changes
included
upregulated
encoded
every
timepoint.
Genes
involved
specific
factor
signaling
pathways
(WNT
Notch),
metabolism
(including
oxidative
stress),
extracellular
matrix
were
altered
cells.
Further
uncovered
heterochronic
genes.
Conclusion
Trisomy
impacts
discrete
earliest
The
results
suggest
metabolic
dysfunction
arises
embryogenesis
may
affect
function
more
broadly.
British Journal of Pharmacology,
Journal Year:
2023,
Volume and Issue:
180(13), P. 1651 - 1673
Published: March 25, 2023
Ageing
is
the
main
risk
factor
common
to
most
primary
neurodegenerative
disorders.
Indeed,
age‐related
brain
alterations
have
been
long
considered
predispose
neurodegeneration.
Although
protein
misfolding
and
accumulation
of
toxic
aggregates
as
causative
events
in
neurodegeneration,
several
other
biological
pathways
affected
by
ageing
also
contribute
pathogenesis.
Here,
we
discuss
evidence
showing
involvement
mechanisms
controlling
neuronal
structure,
gene
expression,
autophagy,
cell
metabolism
neuroinflammation
onset
progression
Furthermore,
review
therapeutic
strategies
currently
under
development
or
future
approaches
designed
normalize
these
pathways,
which
may
then
increase
resilience
cope
with
species.
In
addition
therapies
targeting
insoluble
specifically
associated
each
disorder,
novel
pharmacological
be
part
combined
rescue
function.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(14), P. 3106 - 3106
Published: July 11, 2023
This
comprehensive
narrative
review
explores
the
concept
of
neuro-vulnerability
in
energy
metabolism
regulation
and
its
implications
for
metabolic
disorders.
The
highlights
complex
interactions
among
neural,
hormonal,
pathways
involved
metabolism.
key
topics
discussed
include
role
organs,
hormones,
neural
circuits
maintaining
balance.
investigates
association
between
disorders,
such
as
obesity,
insulin
resistance,
eating
considering
genetic,
epigenetic,
environmental
factors
that
influence
subsequent
dysregulation.
Neuroendocrine
food
intake
expenditure
are
examined,
with
a
focus
on
impact
appetite
dysregulation
altered
expenditure.
neuroinflammation
health
is
discussed,
emphasizing
bidirectional
relationship
neuroinflammatory
processes.
also
evaluates
use
neuroimaging
techniques
studying
their
potential
applications
clinical
settings.
Furthermore,
well
contribution
to
examined.
Potential
therapeutic
interventions
targeting
neuro-vulnerability,
including
pharmacological
treatments
lifestyle
modifications,
reviewed.
In
conclusion,
understanding
crucial
addressing
provides
valuable
insights
into
underlying
neurobiological
mechanisms
health.
Targeting
holds
promise
developing
innovative
strategies
prevention
treatment
ultimately
improving
outcomes.
Aging and Disease,
Journal Year:
2024,
Volume and Issue:
unknown, P. 0 - 0
Published: Jan. 1, 2024
In
the
context
of
an
aging
global
population
and
imperative
for
innovative
healthcare
solutions,
concept
longevity
clinics
emerges
as
a
timely
vital
area
exploration.
Unlike
traditional
medical
facilities,
offer
unique
approach
to
preclinical
prevention,
focusing
on
"prevention
prevention"
through
utilization
clocks
biomarkers
from
healthy
individuals.
This
article
presents
comprehensive
overview
clinics,
encompassing
descriptions
existing
models,
development
proposed
framework,
insights
into
biomarkers,
wearable
devices,
therapeutic
interventions.
Additionally,
economic
justifications
investing
in
are
examined,
highlighting
significant
growth
potential
biotechnology
market
its
alignment
with
goals
achieving
active
longevity.
Anchored
by
Analytical
Center,
framework
underscores
importance
data-driven
decision-making
innovation
promoting
prolonged
enhanced
human
life.
At
present,
there
is
no
universally
accepted
standard
model
clinics.
absence
highlights
need
additional
research
ongoing
improvements
this
field.
Through
synthesis
scientific
practical
considerations,
aims
stimulate
further
discussion
field
ultimately
contributing
advancement
practices
aimed
at
extending
enhancing